B.C.\u2019s Ministry of Health confirmed Friday that the drug coverage for a 10-year-old girl on Vancouver Island who has a rare disease will remain cut off.<\/p>\n
The reaffirming of the Ministry\u2019s decision comes after Health Minister Josie Osborne met with Charleigh Pollock\u2019s parents and Batten disease patient advocates last week.<\/p>\n
In June, the Ministry of Health explained that it was discontinuing its coverage of Brineura, one of the only treatment methods for\u00a0Ceroid Lipofuscinosis Type 2<\/a>\u00a0(CLN2), otherwise known as Batten disease. While it is not a life-saving drug, it aims to slow the progression of the disease.<\/p>\n At the time, Charleigh\u2019s mother, Jori Fales, and Batten disease and family advocate Lori Brown shared that the government\u2019s claims that Charleigh was no longer getting any benefit from taking Brineura were not true.<\/p>\n In an update to the ministry\u2019s decision on Friday, Osborne explained that \u201call of the relevant evidence provided by the patient advocates was already considered by the EDRD expert committees in February 2025, when Charleigh\u2019s physician appealed the decision to discontinue treatment and had the opportunity to provide additional information and meet with them to discuss the case.\u201d<\/p>\n Fales and Brown had also stated that the Ministry\u2019s decision was based on outdated information that did not consider research from the drug manufacturer and two disease experts. They also shared that the scoring system to determine a patient\u2019s suitability for drug treatment is outdated.<\/p>\n \u201cThe Ministry can confirm that the CDA reviewed and evaluated eight separate publications by these two experts. The Ministry also confirms that Biomarin Pharmaceutical, the manufacturer of Brineura, also submitted detailed information to the CDA, including unpublished studies, clinician statements, and materials from these same experts,\u201d she added.<\/p>\n \u201cThe EDRD expert committees have not revised their recommendation to discontinue coverage given that there is no clinical evidence it would provide further benefits for Charleigh,\u201d Osborne stated.<\/p>\n According to the Ministry, the United Kingdom also announced its intention to discontinue coverage for Brineura for Batten disease patients, due to what it says is \u201cthe limited evidence for its long-term effectiveness.\u201d<\/p>\n \u201cB.C.\u2019s EDRD expert committees are often faced with the difficult responsibility of denying or ending drug coverage for patients with other rare and heartbreaking conditions\u2014decisions made for the same clinical reasons as in Charleigh\u2019s case. Importantly, cost is not a factor considered in these patient-level decisions. All provinces, including British Columbia, rely on clinical criteria recommended by Canada\u2019s Drug Agency, following its rigorous, transparent evaluations of all available data and evidence,\u201d Osborne said.<\/p>\n \u201cThis has been one of the most challenging issues that I have worked on since becoming Health Minister, and I take seriously my role to ensure that B.C. has drug review processes that are independent, evidence-based, and treat people equally.<\/p>\n \u201cI know the outcome of this process is not the one anyone was hoping for, most particularly Charleigh\u2019s family. Watching a child face daily challenges that most will never know is heartbreaking beyond words, and I believe that every British Columbian wishes for a world where no child should have to endure such suffering, and no parent should have to navigate such uncertainty.<\/p>\n \u201cWe must all continue to hold hope that ongoing advancements in rare disease research will one day prevent other children and families from experiencing the same suffering, and offer a better future through knowledge, treatment, and ultimately, cures,\u201d Osborne said.<\/p>\n As for why B.C. could not decide to grant Charleigh\u2019s coverage on compassionate grounds, or decide to use Charleigh\u2019s diagnoses and experience for research purposes, Osborne told media on Friday that the EDRD is in the \u201cextremely difficult position of making decisions like these regularly.\u201d<\/p>\n \u201cThere are about 650 other people in British Columbia who receive drugs for very rare diseases, and the committee uses the same rigorous process, and it\u2019s incredibly important that these processes be independent, that they be based in science, and that they be evidence based, but also important that everybody fairly,\u201d Osborne said.<\/p>\n \u201cIt is vitally important that politicians not make these decisions, and guard the door for, really, sidestepping a process that is incredibly important to keep in place, in order to ensure that equity for all patients, and that people are treated fairly.<\/p>\n \u201cThat is my responsibility as minister. \u2026 I think about all of the options and opportunities before us, and I must come back to shepherding and stewarding this incredibly important process.\u201d<\/p>\n B.C. decision disregards Charleigh\u2019s life, her mother says<\/p>\n After receiving the news that the government has not changed its decision to cease coverage of Brineura, Charleigh\u2019s mother took to social media to share her devastation.<\/p>\n Fales says she and the family were informed just shortly before the Ministry made its public announcement.<\/p>\n \u201cI\u2019m disgusted with the complete disregard for my child\u2019s life,\u201d she said. \u201cWe fought so hard.\u201d<\/p>\n \u201cCharleigh, I am so sorry.\u201d<\/p>\n Courtenay-Comox MLA and Critic for Rural Health and Seniors Health Brennan Day says he \u201cstands with Jori.\u201d<\/p>\n \u201cIt is very disappointing that the province decided to not take the lead on this, and show some leadership,\u201d he told 1130 NewsRadio.<\/p>\n Day says B.C. lags behind other jurisdictions on pharmaceutical research and then drug adoption into PharmaCare.<\/p>\n \u201cWe are the last, generally, in the entire country, to adopt drugs onto our coverage list, which doesn\u2019t put us at the front of the pack, despite what the minister said in terms of new research and new pharma products that can lower the cost to health care,\u201d he explained.<\/p>\n \u201cUltimately, in this case, I think the minister is a bit misguided, thinking that British Columbia is leading on this, we\u2019re following, and I see that this decision shows that we\u2019re not willing to show that leadership,\u201d Day shared.<\/p>\n Day claims that the Canada Drug Agency\u2019s final report, which he has reviewed, left it open to the province to step in and choose to continue Charleigh\u2019s drug coverage.<\/p>\n \u201cThey\u2019ve chosen not to, and unfortunately, they\u2019re going to have to wear that,\u201d he said.<\/p>\n \u201cThis is not a discussion about the cost of a medicine. It\u2019s a discussion about a health-care system that\u2019s compassionate enough to do the right thing anyway and make it work. <\/p>\n \u201cThis government spends $5 million by breakfast time on communications experts and spin doctors across the ministries. If the money was wanted, they could find it. They\u2019ve decided not to, in this case, and I think it\u2019s going to be a decision that haunts them for the next several years.\u201d<\/p>\n During Friday\u2019s update, Osborne confirmed that Charleigh\u2019s family may acquire Brineura privately, and pay for the drug \u2014 estimated to cost $844,000 per year \u2014 themselves.<\/p>\n \u201cFundraising is going to be a big part of this,\u201d Day explained. \u201cIt\u2019s unfortunate that it has come this. In a public health-care system like ours, you shouldn\u2019t have to go bankrupt accessing health care.\u201d<\/p>\n \u201cIn this case, it\u2019s going to take a community effort to continue this treatment. And that\u2019s extremely disappointing.\u201d<\/p>\n You can watch CityNews 24\/7 live<\/a> or listen live to 1130 NewsRadio Vancouver<\/a> to keep up to date with this story. You can also subscribe to\u00a0breaking news alerts<\/a>\u00a0sent directly to your inbox.<\/p>\n With files from Srushti Gangdev.<\/p>\n","protected":false},"excerpt":{"rendered":"B.C.\u2019s Ministry of Health confirmed Friday that the drug coverage for a 10-year-old girl on Vancouver Island who…\n","protected":false},"author":2,"featured_media":2292,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58],"tags":[97,243],"class_list":{"0":"post-2291","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/2291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=2291"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/2291\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/2292"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=2291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=2291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=2291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}